A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-7547
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases ; volume:20 ; number:1 ; day:19 ; month:9 ; year:2022 ; pages:1-12 ; date:12.2022
Cost effectiveness and resource allocation ; 20, Heft 1 (19.9.2022), 1-12, 12.2022
- Urheber
-
Katsigianni, Eleni Ioanna
Petrou, Panagiotis
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12962-022-00369-w
- URN
-
urn:nbn:de:101:1-2023021721065828431123
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Katsigianni, Eleni Ioanna
- Petrou, Panagiotis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Improving enzyme replacement therapy for lysosomal storage diseases
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
Correction to: A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
Health care costs of home care enzyme replacement therapy for patients with lysosomal storage diseases in Germany
Lysosomal storage disease: aspartylglycosaminuria
Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
Lysosomal enzyme trafficking factor LYSET in lysosomal catabolism, nutrient generation, and pathology
Neonatal Expanded Screening toward lysosomal storage disorders
Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy
Sphingolipid lysosomal storage diseases: from bench to bedside
The rapidly evolving view of lysosomal storage diseases
Lipid‐induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders
Improving enzyme replacement therapy for lysosomal storage diseases
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
Correction to: A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
Health care costs of home care enzyme replacement therapy for patients with lysosomal storage diseases in Germany
Lysosomal storage disease: aspartylglycosaminuria
Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
Lysosomal enzyme trafficking factor LYSET in lysosomal catabolism, nutrient generation, and pathology
Neonatal Expanded Screening toward lysosomal storage disorders
Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy
Sphingolipid lysosomal storage diseases: from bench to bedside
The rapidly evolving view of lysosomal storage diseases
Lipid‐induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders
Improving enzyme replacement therapy for lysosomal storage diseases
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
Correction to: A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
Health care costs of home care enzyme replacement therapy for patients with lysosomal storage diseases in Germany
Lysosomal storage disease: aspartylglycosaminuria
Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
Lysosomal enzyme trafficking factor LYSET in lysosomal catabolism, nutrient generation, and pathology
Neonatal Expanded Screening toward lysosomal storage disorders
Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy
Sphingolipid lysosomal storage diseases: from bench to bedside
The rapidly evolving view of lysosomal storage diseases